Clinical Trials

Study Title:
A Randomized Phase 2/3 Study of Olaparib Plus Temozolomide Versus Investigator’s Choice for the Treatment of Patients with Advanced Uterine Leiomyosarcoma After Progression on Prior Chemotherapy

For more information about the trial above please contact the study team: Medical University of South Carolina Principal Investigator, Whitney Graybill, at graybill@musc.edu. Study Coordinator, Crystal Knox, at knoxc@musc.edu. Trial opened at the following institutions: Medical University of South Carolina